Sfoglia per Rivista HAEMATOLOGICA
P082 PROGNOSTIC EVALUATION ACCORDING TO THE HAMMERSMITH AND MDACC SCORES OF CML PATIENTS RESISTANT TO IMATINIB BEFORE TREATMENT WITH SECOND-GENERATION TKIS
2011 Breccia, M; Stagno, F; Gozzini, A; Abruzzese, E; Latagliata, R; Russo Rossi, A; Sorà, F; Porrini, R; Vigneri, P; Trawinska, M; Montefusco, E; Sica, S; Specchia, G; Santini, V; Alimena, G
P53 EVALUATION IN 98 CLL PATIENTS BY AMPLICHIP P53 ARRAY REVEALS A HIGH PERCENTAGE OF MUTATIONS AND POLYMORPHISMS
2008 S., Tavolaro; Chiaretti, Sabina; M., Marinelli; M., Messina; DEL GIUDICE, Ilaria; Mauro, Francesca Romana; S., Santangelo; N., Peragine; S., Truong; M. S., De Propris; M., Nanni; Guarini, Anna; Foa, Roberto
P53 EVALUATION IN CLL BY P53 ARRAY: A SIMPLE, SENSITIVE AND SPECIFIC METHOD THAT UNRAVELS A HIGH PERCENTAGE OF POLYMORPHISMS AND MUTATIONS
2008 Chiaretti, Sabina; S., Tavolaro; M., Messina; M., Marinelli; DEL GIUDICE, Ilaria; Mauro, Francesca Romana; S., Santangelo; N., Peragine; S., Truong; M. S., De Propris; M., Nanni; Guarini, Anna; Foa, Roberto
The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia
2015 Allegretti, Matteo; Ricciardi, Maria Rosaria; Licchetta, Roberto; Mirabilii, Simone; Orecchioni, Stefania; Reggiani, Francesca; Talarico, Giovanna; Foa, Roberto; Bertolini, Francesco; Amadori, Sergio; Tafuri, Agostino
Pancreatic pseudocystis following treatment with asparaginase in a patient with acute lymphocytic leukemia
1983 Colombo, R; Deb, G; DE FABRITIIS, Paolo; Moleti, Ml; Pulsoni, Alessandro; Testi, Anna Maria
PARP1 and CHE1 impairment identify a subset of chronic lymphocytic leukemia patients with defective IR-induced apoptosis.
2010 Tavolaro, S; Bacalini, Mg; Peragine, Nadia; Marinelli, Marilisa; Messina, M; Santangelo, S; DEL GIUDICE, Ilaria; Mauro, Francesca Romana; Di Maio, V; Caiafa, P; Ricciardi, Maria Rosaria; Chiaretti, Sabina; Guarini, A; Foà, R; Reale, Anna
Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia
2014 Efficace, F; Rosti, G; Aaronson, N; Cottone, F; Angelucci, E; Molica, S; Vignetti, M; Mandelli, F; Baccarani, M.
Pefloxacin in the treatment of Gram- negative infections in patients with haematologic diseases
1989 Micozzi, Alessandra; Martino, Pietro; R., Raccah; C., Girmenia; Gentile, Giuseppe; S., Santilli; Mandelli, Franco
Pentostatin and rituximab combination for treatment of relapsed/refractory hairy cell leukaemia – a report of 3 cases.
2004 Osuji, N; DEL GIUDICE, Ilaria; Parry Jones, N; Matutes, E; Dearden, C; Catovsky, D.
Peripheral blood CD 34+ from healthy donors mobilized by recombinant human granulocyte colony-stimulating factor for allogeneic transplantation, show the same frequency of colony-forming unit cells (CFU-C) and long-term culture initiating cells (LTC-IC) of bone marrow CD 34+ cells. Whereas they differ in cell-cycle distribution, apoptosis and in-vitro responsiveness to colony-stimulating factors.
1996 Fortuna, A; Tafuri, Agostino; Petrucci, Mt; Ricciardi, Maria Rosaria; Catani, L; Rondelli, D; Fogli, M; Leopardi, G; Ariola, C; Tura, S; Lemoli, R. M.
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma
2007 Gahrton, Gösta; Iacobelli, Simona; Bandini, Giuseppe; Björkstrand, Bo; Corradini, Paolo; Crawley, Charles; Hegenbart, Ute; Morgan, Gareth; Kröger, Nicolaus; Schattenberg, Anton; Schönland, Stefan O; Verdonck, Leo F; Volin, Lisa; de Witte, Theo; Niederwieser, Dietger
Peripheral blood stem cells in Acute Myeloid Leukemia: biology and clinical application.
1996 Aglietta, M; DE VINCENTIIS, A; Lamata, L; Lanza, F; Lemoli, Rm; Menichella, G; Tafuri, Agostino; Zanon, P. E. TURA S.
PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS (PICCS) IN HEMATOLOGICAL PATIENTS: A SAFE AND EFFECTIVE ALTERNATIVE TO THE CENTRAL VENOUS ACCESS
2011 Morano, Sg; Matturro, A; Berneschi, P; Giampaoletti, M; Guerriero, A; Sammarco, A; Latagliata, R; Breccia, M; Girmenia, C; Brunetti, G; Micozzi, A; Chistolini, A; Di Rocco, A; Annechini, G; Foà, R; Alimena, G
Pernicious anemia, vitiligo and positive antiglobulin test: an unusual association.
1989 Pelosio, A; Girelli, Gabriella; Arista, Maria Cristina; Galassi, A; Longhi, C; Massini, R.
Perossidazione lipidica e livelli plasmatici di tocoferoli nella beta-talassemia.
1978 O., Giardini; F., Murgia; Martino, Francesco; B., Spano; G., Maggioni
PERSISTENCE OF THE BCR/ABL GENE IN GREATER THAN 10-YEAR SURVIVORS OF MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHRONIC MYELOID LEUKEMIA
2011 Iori, Ap; Diverio, D; Breccia, M; Valle, V; Di Lascio, A; Torelli, Gf; Latagliata, R; Barberi, W; Natalino, F; Mercanti, C; Nanni, M; Cerretti, R; Perrone, S; Arcese, W; Foà, R
Persistence of the early hemopoietic stem cells after in vitro amplification of Umbilical Cord Blood CD34+ cells.
1996 De Felice, L; Di Pucchio, T; Breccia, M; Carmini, D; Guglielmi, C; Mascolo, Mg; Ricciardi, Maria Rosaria; Screnci, M; Tafuri, Agostino; Arcese, W.
Pharmacokinetics of the reformulated B-domain deleted recombinant factor VIII concentrate using chromogenicand one-stage assays with pooled normal plasma and refacto laboratory standard
2007 Santoro, Cristina; Mazzucconi, Maria Gabriella; Pignoloni, P; Rago, A; Biondo, E; Iorio, A; Ferrante, F; Torelli, F; Agnelli, G; Foa, Roberto
PHASE II MULTICENTRIC EXPLORATIVE STUDY OF INTERMITTENT IMATINIB (IM) TREATMENT (INTERIM) IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA (CML) WHO ACHIEVED A STABLE COMPLETE CYTOGENETIC RESPONSE (CCGR) WITH STANDARD IM THERAPY
2009 Russo, D.; Rosti, G.; Martinelli, G.; Malagola, M.; Mirto, S.; Turri, D.; Gobbi, M; Pierri, I.; Vitolo, U.; Pregno, P.; Di Raimondo, F.; Stagno, F.; Foà, R.; Alimena, G.; Breccia, M; Rambaldi, R.; Intermesoli, T; Saglio, G.; Rege Cambrin, G.; Visani, G.; Nicolini, G.; De Fabritiis, P.; Abruzzese, E.; Nobile, F.; Martino, B.; Fanin, R.; Tiribelli, M.; Galieni, P.; Bigazzi, C.; Liso, V.; Specchia, G.; Angelucci, E.; Usala, E.; Musolino, C.; Russo, S.; Gaidano, G. .; Lunghi, M.; Lauria, F.; Bocchia, M.; Quarta, G.; Girasoli, M.; Bosi, A.; Santini, V.; Fioritoni, G.; Di Lorenzo, R.; Colombi, C.; Fogli, M.; Amabile, M.; De Vivo, A. Baccarani M.
PHASE II MULTICENTRIC EXPLORATIVE STUDY OF INTERMITTENT IMATINIB (IM) TREATMENT (INTERIM) IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA (CML) WHO ACHIEVED A STABLE COMPLETE CYTOGENETIC RESPONSE (CCGR) WITH STANDARD IM THERAPY
2009 Russo, D; Rosti, G; Martinelli, G; Malagola, M; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| P082 PROGNOSTIC EVALUATION ACCORDING TO THE HAMMERSMITH AND MDACC SCORES OF CML PATIENTS RESISTANT TO IMATINIB BEFORE TREATMENT WITH SECOND-GENERATION TKIS | 2011 | Breccia, M; Stagno, F; Gozzini, A; Abruzzese, E; Latagliata, R; Russo Rossi, A; Sorà, F; Porrini, R; Vigneri, P; Trawinska, M; Montefusco, E; Sica, S; Specchia, G; Santini, V; Alimena, G | |
| P53 EVALUATION IN 98 CLL PATIENTS BY AMPLICHIP P53 ARRAY REVEALS A HIGH PERCENTAGE OF MUTATIONS AND POLYMORPHISMS | 2008 | S., Tavolaro; Chiaretti, Sabina; M., Marinelli; M., Messina; DEL GIUDICE, Ilaria; Mauro, Francesca Romana; S., Santangelo; N., Peragine; S., Truong; M. S., De Propris; M., Nanni; Guarini, Anna; Foa, Roberto | |
| P53 EVALUATION IN CLL BY P53 ARRAY: A SIMPLE, SENSITIVE AND SPECIFIC METHOD THAT UNRAVELS A HIGH PERCENTAGE OF POLYMORPHISMS AND MUTATIONS | 2008 | Chiaretti, Sabina; S., Tavolaro; M., Messina; M., Marinelli; DEL GIUDICE, Ilaria; Mauro, Francesca Romana; S., Santangelo; N., Peragine; S., Truong; M. S., De Propris; M., Nanni; Guarini, Anna; Foa, Roberto | |
| The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia | 2015 | Allegretti, Matteo; Ricciardi, Maria Rosaria; Licchetta, Roberto; Mirabilii, Simone; Orecchioni, Stefania; Reggiani, Francesca; Talarico, Giovanna; Foa, Roberto; Bertolini, Francesco; Amadori, Sergio; Tafuri, Agostino | |
| Pancreatic pseudocystis following treatment with asparaginase in a patient with acute lymphocytic leukemia | 1983 | Colombo, R; Deb, G; DE FABRITIIS, Paolo; Moleti, Ml; Pulsoni, Alessandro; Testi, Anna Maria | |
| PARP1 and CHE1 impairment identify a subset of chronic lymphocytic leukemia patients with defective IR-induced apoptosis. | 2010 | Tavolaro, S; Bacalini, Mg; Peragine, Nadia; Marinelli, Marilisa; Messina, M; Santangelo, S; DEL GIUDICE, Ilaria; Mauro, Francesca Romana; Di Maio, V; Caiafa, P; Ricciardi, Maria Rosaria; Chiaretti, Sabina; Guarini, A; Foà, R; Reale, Anna | |
| Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia | 2014 | Efficace, F; Rosti, G; Aaronson, N; Cottone, F; Angelucci, E; Molica, S; Vignetti, M; Mandelli, F; Baccarani, M. | |
| Pefloxacin in the treatment of Gram- negative infections in patients with haematologic diseases | 1989 | Micozzi, Alessandra; Martino, Pietro; R., Raccah; C., Girmenia; Gentile, Giuseppe; S., Santilli; Mandelli, Franco | |
| Pentostatin and rituximab combination for treatment of relapsed/refractory hairy cell leukaemia – a report of 3 cases. | 2004 | Osuji, N; DEL GIUDICE, Ilaria; Parry Jones, N; Matutes, E; Dearden, C; Catovsky, D. | |
| Peripheral blood CD 34+ from healthy donors mobilized by recombinant human granulocyte colony-stimulating factor for allogeneic transplantation, show the same frequency of colony-forming unit cells (CFU-C) and long-term culture initiating cells (LTC-IC) of bone marrow CD 34+ cells. Whereas they differ in cell-cycle distribution, apoptosis and in-vitro responsiveness to colony-stimulating factors. | 1996 | Fortuna, A; Tafuri, Agostino; Petrucci, Mt; Ricciardi, Maria Rosaria; Catani, L; Rondelli, D; Fogli, M; Leopardi, G; Ariola, C; Tura, S; Lemoli, R. M. | |
| Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma | 2007 | Gahrton, Gösta; Iacobelli, Simona; Bandini, Giuseppe; Björkstrand, Bo; Corradini, Paolo; Crawley, Charles; Hegenbart, Ute; Morgan, Gareth; Kröger, Nicolaus; Schattenberg, Anton; Schönland, Stefan O; Verdonck, Leo F; Volin, Lisa; de Witte, Theo; Niederwieser, Dietger | |
| Peripheral blood stem cells in Acute Myeloid Leukemia: biology and clinical application. | 1996 | Aglietta, M; DE VINCENTIIS, A; Lamata, L; Lanza, F; Lemoli, Rm; Menichella, G; Tafuri, Agostino; Zanon, P. E. TURA S. | |
| PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS (PICCS) IN HEMATOLOGICAL PATIENTS: A SAFE AND EFFECTIVE ALTERNATIVE TO THE CENTRAL VENOUS ACCESS | 2011 | Morano, Sg; Matturro, A; Berneschi, P; Giampaoletti, M; Guerriero, A; Sammarco, A; Latagliata, R; Breccia, M; Girmenia, C; Brunetti, G; Micozzi, A; Chistolini, A; Di Rocco, A; Annechini, G; Foà, R; Alimena, G | |
| Pernicious anemia, vitiligo and positive antiglobulin test: an unusual association. | 1989 | Pelosio, A; Girelli, Gabriella; Arista, Maria Cristina; Galassi, A; Longhi, C; Massini, R. | |
| Perossidazione lipidica e livelli plasmatici di tocoferoli nella beta-talassemia. | 1978 | O., Giardini; F., Murgia; Martino, Francesco; B., Spano; G., Maggioni | |
| PERSISTENCE OF THE BCR/ABL GENE IN GREATER THAN 10-YEAR SURVIVORS OF MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHRONIC MYELOID LEUKEMIA | 2011 | Iori, Ap; Diverio, D; Breccia, M; Valle, V; Di Lascio, A; Torelli, Gf; Latagliata, R; Barberi, W; Natalino, F; Mercanti, C; Nanni, M; Cerretti, R; Perrone, S; Arcese, W; Foà, R | |
| Persistence of the early hemopoietic stem cells after in vitro amplification of Umbilical Cord Blood CD34+ cells. | 1996 | De Felice, L; Di Pucchio, T; Breccia, M; Carmini, D; Guglielmi, C; Mascolo, Mg; Ricciardi, Maria Rosaria; Screnci, M; Tafuri, Agostino; Arcese, W. | |
| Pharmacokinetics of the reformulated B-domain deleted recombinant factor VIII concentrate using chromogenicand one-stage assays with pooled normal plasma and refacto laboratory standard | 2007 | Santoro, Cristina; Mazzucconi, Maria Gabriella; Pignoloni, P; Rago, A; Biondo, E; Iorio, A; Ferrante, F; Torelli, F; Agnelli, G; Foa, Roberto | |
| PHASE II MULTICENTRIC EXPLORATIVE STUDY OF INTERMITTENT IMATINIB (IM) TREATMENT (INTERIM) IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA (CML) WHO ACHIEVED A STABLE COMPLETE CYTOGENETIC RESPONSE (CCGR) WITH STANDARD IM THERAPY | 2009 | Russo, D.; Rosti, G.; Martinelli, G.; Malagola, M.; Mirto, S.; Turri, D.; Gobbi, M; Pierri, I.; Vitolo, U.; Pregno, P.; Di Raimondo, F.; Stagno, F.; Foà, R.; Alimena, G.; Breccia, M; Rambaldi, R.; Intermesoli, T; Saglio, G.; Rege Cambrin, G.; Visani, G.; Nicolini, G.; De Fabritiis, P.; Abruzzese, E.; Nobile, F.; Martino, B.; Fanin, R.; Tiribelli, M.; Galieni, P.; Bigazzi, C.; Liso, V.; Specchia, G.; Angelucci, E.; Usala, E.; Musolino, C.; Russo, S.; Gaidano, G. .; Lunghi, M.; Lauria, F.; Bocchia, M.; Quarta, G.; Girasoli, M.; Bosi, A.; Santini, V.; Fioritoni, G.; Di Lorenzo, R.; Colombi, C.; Fogli, M.; Amabile, M.; De Vivo, A. Baccarani M. | |
| PHASE II MULTICENTRIC EXPLORATIVE STUDY OF INTERMITTENT IMATINIB (IM) TREATMENT (INTERIM) IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA (CML) WHO ACHIEVED A STABLE COMPLETE CYTOGENETIC RESPONSE (CCGR) WITH STANDARD IM THERAPY | 2009 | Russo, D; Rosti, G; Martinelli, G; Malagola, M; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile